Curaleaf (OTCMKTS:CURLF – Get Rating) and Jushi (OTCMKTS:JUSHF – Get Rating) are both small-cap consumer discretionary companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, profitability and analyst recommendations.
Valuation & Earnings
This table compares Curaleaf and Jushi’s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Curaleaf | $1.34 billion | 1.48 | -$370.10 million | ($0.54) | -5.87 |
| Jushi | $284.28 million | 0.36 | -$202.32 million | N/A | N/A |
Jushi has lower revenue, but higher earnings than Curaleaf.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Curaleaf | -28.88% | -20.37% | -8.18% |
| Jushi | -66.72% | -161.43% | -32.20% |
Insider & Institutional Ownership
0.0% of Curaleaf shares are held by institutional investors. Comparatively, 0.0% of Jushi shares are held by institutional investors. 21.0% of Jushi shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for Curaleaf and Jushi, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Curaleaf | 0 | 1 | 7 | 0 | 2.88 |
| Jushi | 0 | 4 | 2 | 0 | 2.33 |
Curaleaf currently has a consensus target price of $10.00, indicating a potential upside of 215.46%. Jushi has a consensus target price of $2.55, indicating a potential upside of 392.28%. Given Jushi’s higher probable upside, analysts plainly believe Jushi is more favorable than Curaleaf.
Summary
Curaleaf beats Jushi on 8 of the 11 factors compared between the two stocks.
About Curaleaf
Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment includes the production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how and back office administration, intellectual property licensing, real estate leasing services and lending facilities to medical and adult-use cannabis licensees under management service agreements. The company was founded on November 13, 2014 and is headquartered in New York, NY.
About Jushi
Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of medical and adult-use products. It focuses on building a portfolio of cannabis assets in various jurisdictions in Pennsylvania, Virginia, Ohio, Illinois, California, Nevada, and Massachusetts. The company also offers hemp-based CBD products, including cannabis dry flower, vaporizer forms of cannabis, edibles, cannabis oil in capsules, tinctures, cannabis in topical products, and other cannabis products, as well as vape cartridges, disposables, and concentrates under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. In addition, it operates medical cannabis dispensaries under the BEYOND/HELLO, Nature's Remedy, and NuLeaf brands. The company is headquartered in Boca Raton, Florida.
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.
